Tenet Healthcare Corporation (THC) — Analyst outlook / Analyst consensus target is. Based on 32 analyst ratings, the consensus is bullish — 25 Buy, 7 Hold.
The consensus price target is $258.55 (low: $224.00, high: $288.00), representing an upside of 31.5% from the current price $196.60.
Analysts estimate Earnings Per Share (EPS) of $11.32 and revenue of $20.77B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $33.02 vs est $11.32 (beat +191.7%). 2025: actual $15.61 vs est $16.09 (missed -3%). Analyst accuracy: 66%.
THC Stock — 12-Month Price Forecast
$258.55
▲ +31.51% Upside
Average Price Target
Based on 32 Wall Street analysts offering 12-month price targets for Tenet Healthcare Corporation, the average price target is $258.55, with a high forecast of $288.00, and a low forecast of $224.00.
The average price target represents a +31.51% change from the last price of $196.60.
Highest Price Target
$288.00
Average Price Target
$258.55
Lowest Price Target
$224.00
THC Analyst Ratings
Buy
Based on 32 analysts giving stock ratings to Tenet Healthcare Corporation in the past 3 months
EPS Estimates — THC
66%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $33.02
vs Est $11.32
▲ 65.7% off
2025
Actual $15.61
vs Est $16.09
▼ 3.1% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining.
Revenue Estimates — THC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $20.665B
vs Est $20.774B
▼ 0.5% off
2025
Actual $21.310B
vs Est $21.270B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
